Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma

Por Viardot, Andreas, Goebeler, Marie-Elisabeth, Hess, Georg, Neumann, Svenja, Pfreundschuh, Michael, Adrian, Nicole, Zettl, Florian, Libicher, Martin, Sayehli, Cyrus, Stieglmaier, Julia, Zhang, Alicia, Nagorsen, Dirk, Bargou, Ralf C.
Publicado no Blood (2016)

Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia

Por Gökbuget, Nicola, Dombret, Hervé, Bonifacio, Massimiliano, Reichle, Albrecht, Graux, Carlos, Faul, Christoph, Diedrich, Helmut, Topp, Max S., Brüggemann, Monika, Horst, Heinz-August, Havelange, Violaine, Stieglmaier, Julia, Wessels, Hendrik, Haddad, Vincent, Benjamin, Jonathan E., Zugmaier, Gerhard, Nagorsen, Dirk, Bargou, Ralf C.
Publicado no Blood (2018)

International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia

Por Gökbuget, Nicola, Dombret, Hervè, Ribera, Jose-Maria, Fielding, Adele K., Advani, Anjali, Bassan, Renato, Chia, Victoria, Doubek, Michael, Giebel, Sebastian, Hoelzer, Dieter, Ifrah, Norbert, Katz, Aaron, Kelsh, Michael, Martinelli, Giovanni, Morgades, Mireia, O’Brien, Susan, Rowe, Jacob M., Stieglmaier, Julia, Wadleigh, Martha, Kantarjian, Hagop
Publicado no Haematologica (2016)